1. Home
  2. CRL vs UGI Comparison

CRL vs UGI Comparison

Compare CRL & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • UGI
  • Stock Information
  • Founded
  • CRL 1947
  • UGI 1940
  • Country
  • CRL United States
  • UGI United States
  • Employees
  • CRL N/A
  • UGI N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • UGI Natural Gas Distribution
  • Sector
  • CRL Health Care
  • UGI Utilities
  • Exchange
  • CRL Nasdaq
  • UGI Nasdaq
  • Market Cap
  • CRL 8.0B
  • UGI 8.1B
  • IPO Year
  • CRL 2000
  • UGI N/A
  • Fundamental
  • Price
  • CRL $178.73
  • UGI $38.98
  • Analyst Decision
  • CRL Buy
  • UGI Buy
  • Analyst Count
  • CRL 15
  • UGI 1
  • Target Price
  • CRL $190.15
  • UGI $39.00
  • AVG Volume (30 Days)
  • CRL 1.1M
  • UGI 2.3M
  • Earning Date
  • CRL 11-05-2025
  • UGI 11-20-2025
  • Dividend Yield
  • CRL N/A
  • UGI 3.84%
  • EPS Growth
  • CRL N/A
  • UGI 147.20
  • EPS
  • CRL N/A
  • UGI 3.09
  • Revenue
  • CRL $4,023,704,000.00
  • UGI $7,287,000,000.00
  • Revenue This Year
  • CRL N/A
  • UGI $27.27
  • Revenue Next Year
  • CRL $2.43
  • UGI $2.85
  • P/E Ratio
  • CRL N/A
  • UGI $12.64
  • Revenue Growth
  • CRL N/A
  • UGI 1.07
  • 52 Week Low
  • CRL $91.86
  • UGI $26.73
  • 52 Week High
  • CRL $203.01
  • UGI $39.27
  • Technical
  • Relative Strength Index (RSI)
  • CRL 58.84
  • UGI 86.66
  • Support Level
  • CRL $157.49
  • UGI $34.39
  • Resistance Level
  • CRL $172.39
  • UGI $39.27
  • Average True Range (ATR)
  • CRL 6.13
  • UGI 0.89
  • MACD
  • CRL 0.81
  • UGI 0.49
  • Stochastic Oscillator
  • CRL 98.84
  • UGI 95.59

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About UGI UGI Corporation

UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.

Share on Social Networks: